Some people think using marijuana when you're young can mess with your brain and make you go crazy. But scientists aren't sure if it's really the weed or something else that makes people act that way. Also, even though some people say more kids are smoking weed now, in reality fewer teens are using marijuana since some places made it legal for grown-ups. So it might not be the weed after all that's causing problems for young minds. Read from source...

1. The article conflates correlation with causation when discussing the link between cannabis use and psychosis-related conditions. It is not clear whether cannabis causes these conditions or if a third factor (e.g., genetics, environment) drives both outcomes. Moreover, the study that estimated the rate of cannabis-induced psychosis was based on cases where these conditions emerge, which may not be representative of the general population.

2. The article assumes that teens are particularly vulnerable to cannabis' effects without providing any evidence or explanation for this claim. It is possible that other factors (e.g., age-related brain development) contribute to the correlation between teen cannabis use and psychosis diagnoses later in life.

3. The article implies that legalizing cannabis would increase teen use, but provides no evidence or logical argument for this claim. In fact, some studies suggest that as states legalize cannabis, rates of teen cannabis use are decreasing, possibly due to increased regulation and education about the potential risks of cannabis use.

Neutral with a slight lean towards bearish.

The article presents both sides of the argument regarding the possible link between cannabis use and teen mental health issues. It acknowledges that some studies suggest a correlation between cannabis use and psychosis-related conditions in teens but also points out the limitations of such research, such as confusing correlation with causation and the possibility of other factors driving both. The article also mentions that rates of teen cannabis use are going down as states legalize cannabis, which could be seen as a counterargument to those who would use potential teen psychosis as a reason to limit cannabis legalization.

- Short-term investment: Buy stocks of companies that produce CBD products or offer services related to mental health treatment and prevention. These companies are likely to benefit from the growing demand for alternative therapies and preventive measures as more states legalize cannabis and consumers become aware of its potential psychological effects. Examples include Charlotte's Web, GW Pharmaceuticals, and Teladoc Health.
- Medium-term investment: Invest in exchange-traded funds (ETFs) that track the performance of the cannabis industry or focus on social responsibility and environmental sustainability. These ETFs may provide exposure to a diversified portfolio of cannabis companies, while also considering their impact on society and the environment. Examples include ETFMG Alternative Harvest ETF, Amplify Seymour Cannabis ETF, and iShares MSCI USA ESG Select ETF.
- Long-term investment: Buy stocks of companies that are innovating in the field of mental health research, treatment, or prevention. These companies may develop new drugs, devices, or therapies that could reduce the risk of psychosis-related conditions associated with cannabis use, or improve the quality of life for those who suffer from them. Examples include MindMed, Compass Pathways, and Ketamine Wellness Centers.